Johnson & Johnson: all 3,718 studies

Page 23 of 38. Open to participants first (155), then studies with results posted, then the rest; newest registration first within each.

• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ALS-008176 in Healthy Japanese Adult ParticipantsCompletedNCT02478333Phase 1
• Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple MyelomaApproved for marketingNCT02477891
• Comparison of the Pharmacokinetic Properties of Two Tablet Formulations of Macitentan in Healthy AdultsCompletedNCT02476864Phase 1
• A Safety, Efficacy and Biomarker Study of JNJ-42847922 in Participants With Major Depressive DisorderCompletedNCT02476058Phase 1
• A Study to Investigate the Effect of Increased Gastric pH on the Oral Bioavailability of the Orexin-2 Receptor Antagonist JNJ-42847922 in Healthy ParticipantsCompletedNCT02475161Phase 1
• A Study to Investigate Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of JNJ-54175446 in Healthy ParticipantsCompletedNCT02475148Phase 1
• Relative Bioavailability and Food Effect for Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fixed Dose CombinationCompletedNCT02475135Phase 1
• Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple MyelomaCompletedNCT02474563
• A Study in Participants With Psoriatic Arthritis Attending Dermatology ClinicsCompletedNCT02470481
• A Study to Assess the Relative Bioavailability of JNJ-42756493 TabletsCompletedNCT02466815Phase 1
• Study to Evaluate Efficacy, Safety and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder Without Psychiatric ComorbidityCompletedNCT02464046Phase 2
• Study to Investigate Effects of Repeated Administration of Itraconazole on Pharmacokinetics of JNJ-42847922 in Healthy Male ParticipantsCompletedNCT02455856Phase 1
• A Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell MalignanciesTerminatedNCT02454270Phase 1
• Study to Assess the Absorption, Metabolism and Excretion of 14C-JNJ-63623872 After a Single Dose in Healthy Male ParticipantsCompletedNCT02448004Phase 1
• A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad35.RSV.FA2 Regimens Boosted With Ad26.RSV.FA2 in Healthy Adult ParticipantsCompletedNCT02440035Phase 1
• Early Access Program (EAP) for Ibrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)Approved for marketingNCT02437019
• Safety Study of the PulseRider® in Patients Undergoing Treatment for Bifurcation Intracranial AneurysmsCompletedNCT02435823Not applicable
• Assessment of SMS and Smartphone Interventions for OneTouch Reveal® ExperiencesCompletedNCT02429024Phase 4
• Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy ParticipantsCompletedNCT02426632Phase 1
• Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 (Erdafitinib) in Participants With Advanced Hepatocellular CarcinomaCompletedNCT02421185Phase 1/2
• A Study of a Self-Administered Memory Screening Test With Automated Reporting (SAMSTAR) in Participants With Mild Cognitive ImpairmentCompletedNCT02419183
• Post-Market Clinical Follow-Up Study to Confirm Clinical Performance and Safety of the Codman Enterprise® 2 Vascular Reconstruction Device in the Endovascular Treatment of Intracranial AneurysmsTerminatedNCT02415010
• Registry for Analysis of Compliance in Colombian Participants With Rheumatoid Arthritis Exposed to GolimumabTerminatedNCT02414984
• A Study of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade TherapyCompletedNCT02405858Phase 4
• Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV PatientsCompletedNCT02401737Phase 1
• A Clinical Trial Study of Knee System in Primary Total Knee Arthroplasty in ChinaCompletedNCT02399046Not applicable
• A Clinical Trial Study of Hip System in Primary Total Hip Arthroplasty in ChinaCompletedNCT02399007Not applicable
• A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ 53718678 in Healthy Japanese Adult ParticipantsCompletedNCT02398591Phase 1
• An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.WithdrawnNCT02397395Phase 2
• Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With PsoriasisCompletedNCT02397382Phase 1
• Observational Study of Golimumab Intravenous InfusionTerminatedNCT02390700
• A Crossover Study to Evaluate the Bioavailability of Ibrutinib Suspension and Sprinkle Formulations Compared to Capsules in Healthy AdultsCompletedNCT02390609Phase 1
• Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection.CompletedNCT02387606Phase 2
• A Crossover Study to Evaluate Relative Bioavailability of Simeprevir Age-appropriate Oral Formulation Candidates Compared With 150-milligram (mg) Oral Capsule in Healthy Adult ParticipantsCompletedNCT02385071Phase 1
• Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican PopulationCompletedNCT02385058Phase 4
• Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell MalignancyCompletedNCT02381080Phase 1
• A Study to Evaluate the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy ParticipantsCompletedNCT02376426Phase 1
• A Study to Assess the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy ParticipantsCompletedNCT02376400Phase 1
• User Performance and System Accuracy Evaluations Using Glucose AdjustmentCompletedNCT02374879Not applicable
• Embolization Procedures in the Peripheral Vasculature Using the Magellan™ Robotic SystemTerminatedNCT02369692
• An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)CompletedNCT02365623Phase 2
• A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology SettingCompletedNCT02364531
• Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer DementiaCompletedNCT02360657Phase 1
• Evaluation of a Powered Stapler System on Surgical Interventions Required During Laparoscopic Sleeve GastrectomyCompletedNCT02358785
• A Crossover Study to Evaluate the Relative Oral Bioavailability and Food Effect After Single Dose Administration of JNJ-54861911 Tablet in Healthy Elderly ParticipantsCompletedNCT02355561Phase 1
• Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TBSuspendedNCT02354014Phase 2
• A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic DermatitisCompletedNCT02345928Phase 1
• Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly and and Healthy Younger Adult ParticipantsCompletedNCT02345148Phase 1
• A Study to Evaluate Use of Induced Skin Blisters in Adult Participants With Atopic Dermatitis, Allergic Asthma and Atopic Healthy ParticipantsCompletedNCT02343783Early Phase 1
• An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic PsoriasisCompletedNCT02343744Phase 3
• A Study to Evaluate the Absolute Bioavailability of Intranasal and Oral Esketamine and the Effects of Clarithromycin on the Pharmacokinetics of Intranasal Esketamine in Healthy ParticipantsCompletedNCT02343289Phase 1
• Study of Acute Uncomplicated Seasonal Influenza A in Adult SubjectsCompletedNCT02342249Phase 2
• Efficacy and Safety Study of Loperamide Hydrochloride/Simethicone Chewable Tablet in Treatment of Acute Diarrhea With Abdominal Discomfort and FlatulenceCompletedNCT02340481Phase 3
• Evaluation of Post-Operative Recovery in ATTUNE® Total Knee ArthroplastyCompletedNCT02339610
• First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1CompletedNCT02339207Phase 1
• Powered Surgical Stapler in VATS Lung Resection Procedures in ChinaCompletedNCT02338583
• Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002CompletedNCT02336698Phase 3
• Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001CompletedNCT02336685Phase 3
• A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy ParticipantsCompletedNCT02325050Phase 1
• Study of Acetaminophen (ACE) in Post-operative Dental PainCompletedNCT02320708Phase 2
• PS150 Total Knee Arthroplasty Outcomes RegistryCompletedNCT02319291
• A Safety and Immunogenicity Study of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy ParticipantsCompletedNCT02313077Phase 1
• Correlation of LONGterm Wrist ACTigraphy Recorded Physical Performance & 6-minute Walk Distance in Patients With Pulmonary Arterial HypertensionWithdrawnNCT02309463
• Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy ParticipantsCompletedNCT02307864Phase 1
• Safety, Tolerability and Immunogenicity Study of 2 Dose Levels of Trimeric Glycoprotein140 (gp140) in Healthy Adult VolunteersCompletedNCT02304185Phase 1
• Study of Safety, Efficacy of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3007CompletedNCT02301234Phase 3
• Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum DisorderCompletedNCT02299700
• A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type PsoriasisCompletedNCT02295865Phase 2
• An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip InvolvementTerminatedNCT02293681
• Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3003CompletedNCT02289716Phase 3
• A Pharmacokinetics, Pharmacodynamics and Safety Study of Single Dose of Rivaroxaban in Participants With End-Stage Renal Disease (ESRD) on Maintenance HemodialysisCompletedNCT02289703Phase 1
• Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable SchizophreniaCompletedNCT02288845Phase 2
• A Trial of the Jejunal Diversion ProcedureCompletedNCT02283632Not applicable
• A Safety, Tolerability and Pharmacokinetics Study of a Single Intravenous Dose of JNJ-49122944 in Healthy Male ParticipantsCompletedNCT02280018Phase 1
• An Efficacy and Safety Study of a 8 or 12-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naive and Experienced Participants With Chronic Genotype 4 Hepatitis C Virus InfectionCompletedNCT02278419Phase 2
• A Prospective Patient Registry of Patients Exposed to BedaquilineCompletedNCT02274389
• A Study to Assess the Severity of Psoriasis in Brazilians Participants With Chronic Plaque-type PsoriasisCompletedNCT02274363
• A Study to Evaluate the Effects of Ibrutinib on Cardiac Repolarization in Healthy ParticipantsCompletedNCT02271438Phase 1
• A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple MyelomaCompletedNCT02268890Phase 4
• A Study to Evaluate Bioavailability, Food Effect, Safety and Tolerability of a Solid Dosage Formulation of JNJ-54861911 in Healthy Older Male ParticipantsCompletedNCT02260700Phase 1
• A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's DiseaseCompletedNCT02260674Phase 2
• Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic SclerosisCompletedNCT02260557Phase 2
• LINEAR II - LME-159 Evaluation of a Multi-Electrode Linear Type Ablation CatheterCompletedNCT02257060Phase 1
• Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed GlioblastomaTerminatedNCT02254954Phase 1
• A Clinical Study of a Spine Fusion System in Vertebral Body Fusion SurgeryCompletedNCT02252185Not applicable
• Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque PsoriasisTerminatedNCT02243787Phase 1/2
• Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent AsthmaTerminatedNCT02243189Phase 1
• Coherex WAVECREST I Left Atrial Appendage Occlusion StudyCompletedNCT02239887
• A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical CareCompletedNCT02236637
• A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176CompletedNCT02231671Phase 1
• Study to Assess the Relative Bioavailability of Orally Administered JNJ-42756493 Tablet Versus JNJ-42756493 Capsule in Healthy ParticipantsCompletedNCT02231489Phase 1
• A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42847922 in Healthy ParticipantsCompletedNCT02230878Phase 1
• Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)CompletedNCT02230059
• Bioequivalence Study of Abiraterone Acetate Coated and Uncoated Tablet Formulations in Healthy Male ParticipantsCompletedNCT02230046Phase 1
• Study to Assess Drug-Drug Interaction Between Itraconazole or Gemfibrozil and JNJ-56021927CompletedNCT02230033Phase 1
• Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in KoreaCompletedNCT02229344
• Efficacy and Safety of Prucalopride in Combination With Polyethylene Glycol or Lactulose in Women With Chronic ConstipationCompletedNCT02228616Phase 4
• Study to Assess the Effects of Esketamine on Safety of On-road Driving in Healthy ParticipantsCompletedNCT02228239Phase 1
• Follow-up Study After Bankart Repair Using MG-1CompletedNCT02228226
• Safety, Pharmacokinetics, and Pharmacodynamics Study of Single Dose of CNTO 3649 in Healthy Adult Men and Multiple Doses of CNTO 3649 in Participants With Type 2 Diabetes MellitusCompletedNCT02224118Phase 1

← Johnson & Johnson overview and focus areas